- Home
- KALU vs AVDL Comparison
KALU vs AVDL Comparison
Compare KALU & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALU
- AVDL
- Stock Information
- Founded
- KALU 1946
- AVDL 2015
- Country
- KALU United States
- AVDL Ireland
- Employees
- KALU N/A
- AVDL N/A
- Industry
- KALU Metal Fabrications
- AVDL Biotechnology: Pharmaceutical Preparations
- Sector
- KALU Industrials
- AVDL Health Care
- Exchange
- KALU Nasdaq
- AVDL Nasdaq
- Market Cap
- KALU 1.1B
- AVDL 786.3M
- IPO Year
- KALU 1991
- AVDL 1996
- Fundamental
- Price
- KALU $70.05
- AVDL $8.02
- Analyst Decision
- KALU Buy
- AVDL Strong Buy
- Analyst Count
- KALU 2
- AVDL 6
- Target Price
- KALU $90.00
- AVDL $20.00
- AVG Volume (30 Days)
- KALU 84.8K
- AVDL 1.8M
- Earning Date
- KALU 02-19-2025
- AVDL 03-03-2025
- Dividend Yield
- KALU 4.40%
- AVDL N/A
- EPS Growth
- KALU 252.66
- AVDL N/A
- EPS
- KALU 2.90
- AVDL N/A
- Revenue
- KALU $2,980,300,000.00
- AVDL $138,160,000.00
- Revenue This Year
- KALU N/A
- AVDL $515.63
- Revenue Next Year
- KALU $6.84
- AVDL $49.32
- P/E Ratio
- KALU $24.16
- AVDL N/A
- Revenue Growth
- KALU N/A
- AVDL 1523.50
- 52 Week Low
- KALU $60.71
- AVDL $7.39
- 52 Week High
- KALU $102.42
- AVDL $19.09
- Technical
- Relative Strength Index (RSI)
- KALU 38.47
- AVDL 35.71
- Support Level
- KALU $69.34
- AVDL $7.40
- Resistance Level
- KALU $72.19
- AVDL $8.07
- Average True Range (ATR)
- KALU 2.17
- AVDL 0.35
- MACD
- KALU -0.07
- AVDL 0.08
- Stochastic Oscillator
- KALU 11.83
- AVDL 34.33
About KALU Kaiser Aluminum Corporation
Kaiser Aluminum Corp produces and sells semi-fabricated specialty aluminum products predominantly to industrial customers. Its products include fabricated aluminum mill products such as flat-rolled (plate, sheet, and coil), extruded (rod, bar, hollows, and shapes), drawn (rod, bar, pipe, tube and wire) and certain cast aluminum products. Geographically, the company generates majority of its revenue from United States.
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.